Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
USD | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
% Growth | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | | |
| | | | | | | | | | | | |
Cost of Revenue | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (0) | | (0) |
Gross Profit | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (0) | | (0) |
% Revenue | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | | NA |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (0) | (2) | (3) | (2) | (4) | (5) | (6) | (5) | (3) | (5) | | (6) |
Other Inc / (Exp) | (21) | (2) | (1) | (65) | 3 | (0) | (0) | (0) | (0) | (0) | | (0) |
Total Operating Exp | (21) | (4) | (3) | (68) | (1) | (5) | (6) | (5) | (3) | (5) | | (7) |
| | | | | | | | | | | | |
Operating Income | (21) | (4) | (3) | (68) | (1) | (5) | (6) | (5) | (3) | (5) | | (7) |
% Revenue | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | | NA |
| | | | | | | | | | | | |
Interest Expense | 0 | 0 | 0 | (0) | (0) | 0 | 0 | 0 | (0) | (0) | | (0) |
Pre-tax Income | (21) | (4) | (3) | (68) | (1) | (5) | (6) | (5) | (3) | (5) | | (7) |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | 36 | (0) | 0 | 20 | 1 | 0 | 0 | (0) | (0) | (0) | | (0) |
Net Income to Company | 14 | (5) | (3) | (48) | 0 | (5) | (6) | (5) | (3) | (5) | | (7) |
% Margin | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | | NA |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 14 | (5) | (3) | (48) | 0 | (5) | (6) | (5) | (3) | (5) | | (7) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 14 | (5) | (3) | (48) | 0 | (5) | (6) | (5) | (3) | (5) | | (7) |
% Margin | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | | NA |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.35 | (0.11) | (0.08) | (1.18) | 0.01 | (0.12) | (0.14) | (0.13) | (0.09) | (0.13) | | (0.11) |
Diluted EPS (Continuing Ops) | 0.35 | (0.11) | (0.08) | (1.18) | 0.01 | (0.12) | (0.14) | (0.13) | (0.09) | (0.13) | | (0.11) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 40.79 | 40.74 | 40.74 | 40.74 | 40.74 | 40.74 | 40.74 | 40.74 | 40.74 | 40.74 | | 70.21 |
WA Diluted Shares Out. | 40.79 | 40.74 | 40.74 | 40.74 | 40.74 | 40.74 | 40.74 | 40.74 | 40.74 | 40.74 | | 70.21 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | (21) | (4) | (3) | (68) | (1) | (5) | (6) | (5) | (3) | (5) | | (7) |
Addback: Net Interest Expense | (0) | 0 | 0 | 0 | 0 | (0) | (0) | (0) | 0 | 0 | | 0 |
Addback: Other Non Operating Expenses, Total | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | (0) | 0 | 0 | 64 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | (3) | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 18 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | (1) | (3) | (3) | (3) | (4) | (5) | (6) | (5) | (3) | (5) | | (7) |
% Margin | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | | NA |
| | | | | | | | | | | | |
Adjusted EBIT | (1) | (3) | (3) | (3) | (4) | (5) | (6) | (5) | (3) | (5) | | (7) |
% Margin | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | | NA |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 14 | (5) | (3) | (48) | 0 | (5) | (6) | (5) | (3) | (5) | | (7) |
Addback: Unusual Items | 18 | 0 | 0 | 65 | (3) | 0 | 0 | 0 | 0 | 0 | | 0 |
Less: Tax Benefit of Unusual Items (26%) | (5) | 0 | 0 | (17) | 1 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted Net Income | 28 | (5) | (3) | 0 | (2) | (5) | (6) | (5) | (3) | (5) | | (7) |
% Margin | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | | NA |